Real-time enrollment status for this melanoma (skin cancer) clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 6:36 PM UTC
| NCT Number | NCT07287917 |
| Recruiting Status | Recruiting |
| Condition | Melanoma (Skin Cancer) |
| Phase | PHASE1 |
| Target Enrollment | 92 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Aminex Therapeutics, Inc. |
| Last Updated on CT.gov | July 15, 2026 (Jul 15, 2026) |
As of August 28, 2026: Clinical trial NCT07287917 is currently recruiting participants. This phase1 study for melanoma (skin cancer) is actively seeking new participants at 17 locations across the United States. The study is sponsored by Aminex Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07287917 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07287917 was last updated Jul 15, 2026 (July 15, 2026). HelloStudys verifies this status automatically.